Ameloblastin is a tooth-specific extracellular matrix protein that is thought to play a role in enamel crystal formation in the developing dentition. The murine ameloblastin promoter functions in a cell type-specific manner and contains cis-acting elements that function to both enhance and suppress transcription. The objective of this study was to determine if the transcription factor Cbfa1, known to be essential for transcription of other mineralized tissue genes, is also required for ameloblastin transcription. Sitedirected mutagenesis of the Cbfa1 binding site (-248 bp) termed OSE2, decreased ameloblastin promoter activity by greater than 50% in ameloblast-like cells. No differences in promoter activity were observed in two other oral tissue-derived cell lines transfected with similar constructs. Nuclear factor binding to the ameloblastin promoter was also shown to be cell type-specific and was altered by site-specific mutations in the OSE2 site. Cbfa1 was specifically shown to participate in the DNA-protein complexes between nuclear factors and the ameloblastin OSE2 site by super shift electrophoretic mobility shift assays. The findings that Cbfa1 interacts with functionally important regions of the ameloblastin promoter while promoter activity is diminished in constructs containing site-directed mutations in the Cbfa1 site indicate that Cbfa1 possesses an important function in transcription of the ameloblastin gene.
Summary
Ameloblastin is a tooth-specific extracellular matrix protein that is thought to play a role in enamel crystal formation in the developing dentition. The murine ameloblastin promoter functions in a cell type-specific manner and contains cis-acting elements that function to both enhance and suppress transcription. The objective of this study was to determine if the transcription factor Cbfa1, known to be essential for transcription of other mineralized tissue genes, is also required for ameloblastin transcription. Sitedirected mutagenesis of the Cbfa1 binding site (-248 bp) termed OSE2, decreased ameloblastin promoter activity by greater than 50% in ameloblast-like cells. No differences in promoter activity were observed in two other oral tissue-derived cell lines transfected with similar constructs. Nuclear factor binding to the ameloblastin promoter was also shown to be cell type-specific and was altered by site-specific mutations in the OSE2 site. Cbfa1 was specifically shown to participate in the DNA-protein complexes between nuclear factors and the ameloblastin OSE2 site by super shift electrophoretic mobility shift assays. The findings that Cbfa1 interacts with functionally important regions of the ameloblastin promoter while promoter activity is diminished in constructs containing site-directed mutations in the Cbfa1 site indicate that Cbfa1 possesses an important function in transcription of the ameloblastin gene.
Introduction
The mineralized tissues that comprise the mammalian dentition are formed by the synthesis of a tissue-specific extracellular matrix that facilitates the initiation and orientation of inorganic hydroxyapatite crystallites. Enamel is an oral epithelial-derived mineralized tissue, while dentin and cementum are formed by cranial neural crest-derived ectomesenchyme (1,2). Because enamel is an epithelial-derived tissue that does not contain collagenous proteins, it is unique among the mineralized tissues in vertebrates.
Another distinguishing feature of enamel is that, unlike bone and dentin, the organic extracelluar matrix that influences initial crystallite formation is essentially lost during tissue maturation resulting in a tissue that is greater than 98% mineral (3) (4) (5) .
Tooth development is dependent on the coordinated expression of several genes, some of which are unique to the developing tooth (6, 7) . Because extracellular matrix molecules are thought to guide the unique size, shape and orientation of the crystallites forming enamel, it is essential that the mechanisms that regulate their expression be accurately controlled. Precision in the timing of enamel matrix gene expression therefore dictates the supramolecular assembly of the framework that directs crystallite growth and ultimately influences its biomechanical properties (3, 8, 9) . The principal secretory products of the enamel matrix-secreting ameloblast have been classified into two major categories: the amelogenins that make up about 90% of the enamel extracellular matrix 4 in dentin and cementum formation has not been established. Localization of ameloblastin near crystal growth sites suggests a role in enamel crystal formation (18, 19) . Therefore, resolving the molecular events directing the control of ameloblastin gene expression during tooth formation is an essential element in understanding how the enamel matrix is secreted, assembled and functions to guide biomineralization.
The cloning and initial characterization of murine ameloblastin promoter suggested that regulatory regions of the murine ameloblastin promoter function in a cell-specific manner (20) . Sequential 5'-deletion mutants encompassing DNA sequences from -1616 bp to -781 bp exhibited high promoter activity in ameloblast-like LS8 cells, whereas the promoter activity decreased to 50% of the full-length construct in the -781 bp and -477 bp regions. The -217 bp promoter region regained promoter activity that approached the activity of the full length promoter construct suggesting that both positive and negative cis-acting regions may be involved in ameloblastin transcriptional regulation. The ameloblastin promoter contains several potential cis-regulatory sites within functionally important promoter regions including AP1, CF2-II, Kruppel and OSE2 sites (20) .
The osteoblast specific element (OSE2), first described in the osteocalcin gene 2 promoter and later in several other genes involved in biomineralization, has a consensus core sequence AACCAC that binds the transcription factor Cbfa1 (core binding factor A1) (21) . Cbfa1, also known as Polyoma Enhancer Binding Protein 2 (PEBP2) or Acute Myloid Leukemia 3 (AML3) is an essential transcription factor for osteoblast differentiation and function (22) . Alternate splicing of the first three exons of Cbfa1 mRNA results in at least three Cbfa isoforms; Cbfa1/Osf2, Cbfa1/Iso and Cbfa/original by guest on October 30, 2017 http://www.jbc.org/
Downloaded from
Cbfa1 and ameloblastin transcription 5 that contain exons 1-3, lack exon 1 or lack exons 1 & 2, respectively (23) . The largest isoform, Cbfa1/Osf2, has been described as the predominant isoform functioning in osteoblast lineage progression and is referred to as Cbfa1 in this report (22) .
Recently, several genes related to osteoblast differentiation and bone matrix formation have been reported to contain OSE2 sequences in their promoter regions suggesting that Cbfa1 may be a principal gene controlling osteoblast function (22, (24) (25) (26) (27) . Furthermore, targeted disruption of Cbfa1 in mice results in cessation of skeleton formation and haploinsufficiency in humans causes cleidocranial dysplasia (CCD), a genetic disorder with malformations in a number of tissues including bone (28) (29) (30) . In addition to a critical role in bone formation, Cbfa1 also has been suggested to support a more general role in the differentiation of mineralized connective tissues. For example, dental abnormalities such as supernumerary teeth and delayed tooth eruption associated with CCD suggest that Cbfa1 may also participate in tooth formation and eruption.
To understand the involvement of Cbfa1 in ameloblastin gene transcription, we have analyzed ameloblastin promoter function in cells derived from three different oral tissues.
The finding that Cbfa1 interacts with functionally important regions of the ameloblastin promoter while promoter activity is diminished in constructs containing site-directed mutations in the Cbfa1 site suggest that Cbfa1 is involved in the transcription of the ameloblastin gene. The mouse enamel organ epithelial cell line, LS8, is an immortalized ameloblast-like cell line that expresses enamel specific genes such as amelogenin and ameloblastin (31) .
Experimental Procedures

Plasmids
Human gingival fibroblasts and pulp fibroblasts were generated from primary explants. 
RNA Isolation and Analysis
Total RNA from MC3T3, LS8, human gingival fibroblast and human pulp fibroblasts was extracted by a guanididium isothiocyanate method (Trizol, Life Technologies).
RNA was quantified by optical density (A 260 ) and stored at -80 0 C until analyzed. One µg of total RNA was used for cDNA synthesis (cDNA synthesis system, Life Technologies).
cDNAs were amplified by PCR using mouse and human specific primers complimentary to the 5' region of Cbfa1 (accession numbers AF010284 and AF053949). Mouse PCR products were separated in 1% agarose gels and were visualized by ethidium bromide. The identity of the PCR products was confirmed by Southern blot analysis and DNA sequencing, using standard molecular biology techniques (32).
Southern Blot Analysis
One µl of the PCR reaction was fractionated in 1% agarose gel. DNA was transferred to the nylon membrane by a capillary transfer method, UV crosslinked and probed for Cbfa1 expression. The probe was prepared by gel purifying a 1.5 kb Eco R1 fragment from a full length Cbfa1-containing cDNA plasmid (gift from P. Ducy) (22) . The probe was random prime labeled using the Prime it II kit (Stratagene, La Jolla CA). The membrane was prehybridized in a high temperature prehybridization solution containing 6x SSPE, 5x Denhardt's solution, 0.5% SDS, 50ug/ml denatured salmon sperm DNA and 10% Dextran sulphate for at least 3 hours at 65 o C. The labeled probe (1x10 6 cpm/ml) was added to hybridization solution (6x SSPE, 5x Denhardt's solution. 0.5% SDS.
100ug/ml denatured DNA and 10% Dextran sulphate) and was hybridized overnight at 65 0 C The blot was washed in 1 x SSC/0.1% SDS at room temperature for 30 minutes (three washes of 10 minutes each), 0.1 x SSC/0.1% SDS at room temperature for 20 minutes (two washes of 10 minutes each) followed by a final wash in the latter solution at 65 0 C The membrane was exposed to the X-ray film overnight and autoradioraphed.
Nuclear Extract Preparation and Electrophoretic Mobility Shift Assays (EMSA)
Nuclear extracts were prepared from cultured cells by the method of Dignam (33 
Results
Cbfa1 Binding Sites in Ameloblastin Promoter-
Sequence analysis of the mouse ameloblastin promoter for putative cis-acting regions revealed two potential Cbfa1 binding elements termed osteoblast specific binding element 2 (OSE2) at positions -248 and -1391 bp relative to the transcription start site (Fig. 1) . These elements have a consensus core sequence (AACCAC) as described in several other genes involved in bone mineralization (22) . The proximal OSE2 site located at position -248 bp has a reversed orientation. This Cbfa1 site is located within a promoter region that expresses high level of ameloblastin promoter activity in ameloblast-like cells, but is inactive in other oral tissues-derived cells such as human gingival fibroblasts (HGF) and human pulp fibroblasts (HPF) (20) . The distal OSE2 site (-1391 bp) is located outside the minimal promoter region and we therefore studied the role of the proximal OSE2 site in ameloblastin promoter function.
The Proximal OSE2 Site is Required for Full Ameloblastin Promoter Activity-
Site directed mutagenesis of the proximal OSE2 site (-248 bp) was performed to determine the importance of this OSE2 site in ameloblastin promoter activity in ameloblast-like cells. Two different oligonucleotides possessing 2 bp mutations within the OSE2 core sequence (Ambn m1 and Ambn m2) were used to generate mutant constructs pAmbn-271m1 and pAmbn-271m2, respectively (Table 1 ; Fig. 1 ). Both substitution mutations were generated in the context of pAmbn-271-luc, a construct that contains 271 bp of 5'-flanking sequence of the ameloblastin promoter and exhibits high-level promoter activity in LS8 cells and minimal activity in human gingival fibroblasts and human pulp fibroblasts ( Fig. 2A) . When promoter activity of the wild type promoter and the mutant promoter constructs were compared in transient transfection assays, promoter activity in constructs containing the mutated OSE2 sites was significantly reduced and consistently ranged from between 40-60% of the wild type promoter ( Fig.   2A ). Promoter activity was also diminished when the proximal OSE2 site was mutated in the context of the much larger full-length ameloblastin promoter, pAmbn-1616 (Fig. 2B) .
The wild type construct pAmbn-1616 also had high expression levels in ameloblast-like cells and minimal activity in either gingival or pulp fibroblasts. Although the decrease in pAmbn-1616m1 promoter activity was not statistically significant, the consistent reduction in promoter activity with a 2 bp mutation in the proximal OSE2 site in the context of a 1.6 kb promoter confirms the findings with pAmbn-271 and suggests that this site is required for full transcriptional activity
Cbfa1 is Expressed in MC3T3, LS8, HGF and HPF Cells-
Cbfa1 is expressed in the mammalian dentition and is temporally and spatially regulated during tooth development (34) . Reverse transcriptase-PCR analysis showed that Cbfa1 transcripts were expressed in ameloblast-like LS8 and pre-osteoblastic MC3T3-E1 murine cell lines. Cbfa1 transcripts were also expressed in human gingival and pulp fibroblasts. Both human and mouse specific primers were designed to amplify the 5' (Fig.3A) . PCR products of 402 bp were observed in HGF and HPF (Fig. 3B ). All PCR products were confirmed by DNA sequencing.
Binding of Cbfa1 to Ameloblastin Promoter is Altered by Mutations in the OSE2 Site-
The significant decrease in promoter activity produced by site directed mutagenesis of the OSE2 site in the context of either pAmbn-271 or pAmbn-1616 suggested that specific binding of transcription factors to this site may serve an essential function in transcription of the ameloblastin gene. Therefore, electrophoretic mobility shift assays (EMSAs) were performed to determine if Cbfa1, or other nuclear proteins expressed by LS8 cells would interact with the OSE2 site present within the ameloblastin promoter. A radiolabeled, double-stranded oligonucleotide probe was prepared from this region (Ambn wt, Table 1) of the ameloblastin promoter and was incubated with nuclear extracts from LS8 cells or human pulp fibroblasts ( Fig. 4A and B) . Two discrete DNA-protein complexes were formed between the Ambn wt probe and nuclear extracts derived from LS8 cells ( containing Ambn wt probe and nuclear extracts from the pulp fibroblasts ( Fig. 4B lane 3) suggesting that distinct differences in trans-acting factors between the two cells types contribute to the cell-specific promoter activity demonstrated in ameloblast-like cells.
To determine the specificity of nuclear factor binding to the OSE2 site, EMSAs were performed with the Ambn wt probe and similar oligonucleotides containing substitution mutations within the OSE2 core sequence. The oligonucleotide probes contained the same substitution mutations that were used to illustrate reduced functional activity in 4A lane 4 and 4B lane 6) whereas binding was unchanged in HPF (Fig. 4B lane 3 and 7) .
In contrast, the lower DNA-protein complex was abolished when LS8-derived nuclear proteins were incubated with the m2 probe (Fig 4A lane 6 and 4B lane 10) . The intensity of binding in DNA-protein complexes with probe m2 and HPF nuclear extracts was diminished but not completely abolished ( Fig. 4B lane 11) . Taken together, results from EMSA and transfection experiments suggest that nuclear factors from ameloblast-like cells show a degree of specificity for the OSE2 core sequence in this functionally important region of the ameloblastin promoter.
Cbfa1 participates in the DNA-protein interactions between nuclear factors and the ameloblastin OSE2 sequence-
The association of Cbfa1 in DNA-protein binding to the Ambn wt promoter was further established by competition studies with wild type and mutant probes known to specifically bind Cbfa1 (Table 1) . The murine OSE2 is a cis-acting element in the promoter of the mouse osteocalcin gene that binds Cbfa1 and together with other cisacting sites participates in the determination of the osteoblast phenotype (21) . Mutations in this site abolish Cbfa1 binding and affect osteoblast differentiation.
The specificity of the Cbfa1 binding to the ameloblastin promoter was demonstrated by competition assays (Fig. 5) . Increasing amounts of unlabeled wild type and mutated by guest on October 30, 2017 http://www.jbc.org/ probes were used as competitors. As also demonstrated in figure 4 , nuclear extracts from LS8 cells form two DNA-protein complexes with the wt probe ( Fig. 5 lane 2) . Both of these complexes were competed by 50, 100 and 150-fold molar excess unlabeled wild type probe (Fig. 5 lanes 3, 4 and 5) . The binding pattern observed with the m2 probe and nuclear extracts from LS8 cells was similar to binding with the wt probe, but exhibited slightly less competition. (Fig. 5 lanes 9, 10 and 11 ). No significant competition was seen with probe m1 (Fig. 5 lanes 6, 7 and 8 ) suggesting that the mutated Cbfa1 site could not compete for Cbfa1 binding.
To ascertain the involvement of Cbfa1 in the DNA-protein complex formation, nuclear extracts from LS8 cells were co-incubated with and without anti-Cbfa1 antisera. DNAprotein complexes exhibited a modified electrophoretic mobility when anti Cbfa1 antisera was added to the reaction (Fig 6 Lane 3) . A portion of the DNA-protein complex was supershifted by Cbfa1-specific antiserum in the reaction mixture confirming the interaction of Cbfa1 in the ameloblastin promoter. A supershifted complex by anti Cbfa1 antiserum addition was also observed in HPF extracts (Fig. 6 lane 5) . Although Cbfa1 is clearly important for the regulation of genes involved in bone formation, it does not function exclusively in bone. Cbfa1 is expressed in ameloblasts and odontoblasts, two cell types that synthesize the extracellular matrix of enamel and dentin, respectively (34, 42) . In addition to the well-described skeletal defects in mice with targeted disruption of Cbfa1, these mice also exhibit defects in the development of the dentition. While early events regulating the initiation of odontogenesis appear to be unaffected, the absence of Cbfa1 adversely affects late stage differentiation of ameloblasts and odontoblasts in molar teeth, thus delaying the normal developmental process (34) . In humans, the development of the dentition may also be delayed in patients with cleidocranial dysplasia (43). Other dental findings in cleidocranial dysplasia include delayed dental eruption, irregular dentin matrix, hypoplastic enamel and supernumerary teeth (44-46). Therefore, Cbfa1 may play a broader role in the development of mineralized tissues of vertebrates including both bones and teeth.
We upper complex is provided by the observation that Ambn m1 was unable to compete for nuclear factor binding to the wild type probe (Fig. 5 ). In the supershift experiments the upper complex was not attenuated (Fig. 6 ) and may reflect an unfavorable stoichiometry of proteins and DNA used in the assay rather than a failure to compete for binding. Like 6, 7, 8) , Ambn m2 (lane 9, 10, 11) . The arrowheads designate the two DNA-protein complexes formed with LS8 nuclear extracts and the wild type ameloblastin probe. 
